Skip to main content
Toggle navigation
Login
Home
Back
Favorite
0
Like
Facebook
Tweet
Session VI: Immune Checkpoint Inhibitors for NSCLC
Debate: How to Handle PD-L1 > 50% - Use Pembrolizumab alone
Saturday, October 15, 2022
9:25 AM – 9:35 AM
Debate Speaker(s)
Edward B. Garon, MD, MS
University of California, Los Angeles